Associated Papers
Functional assays in Drosophila facilitate classification of variants of uncertain significance associated with rare diseases.
Mok JW et al.
Genome Research, 2025
40467338 (PubMed )
Supplement: Supplemental_Table_S1.xlsx › Supplemental_Table1
Advances in kidney disease: pathogenesis and therapeutic targets.
Boima V et al.
Frontiers in Medicine, 2025
APOL1-G2 accelerates nephrocyte cell death by inhibiting the autophagy pathway.
Zhu JY et al.
Disease Models & Mechanisms, 2023
Apolipoprotein L1 risk genotypes in Ghanaian patients with systemic lupus erythematosus: a prospective cohort study.
Blazer A et al.
Lupus Science & Medicine, 2021
Maternal variants within the apolipoprotein L1 gene are associated with preeclampsia in a South African cohort of African ancestry.
Thakoordeen-Reddy S et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2020
APOL1 Genetic Variants Are Associated with Serum-Oxidized Low-Density Lipoprotein Levels and Subclinical Atherosclerosis in South African CKD Patients.
Hassan MO et al.
Nephron, 2020
Fetal-Not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry.
Reidy KJ et al.
American Journal of Human Genetics, 2018
30173819 (PubMed )
Supplement: mmc1.pdf
ApoL1 renal risk variants induce aberrant THP-1 monocyte differentiation and increase eicosanoid production via enhanced expression of cyclooxygenase-2.
Lee H et al.
American Journal of Physiology. Renal Physiology, 2018
Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection.
Cuypers B et al.
Mbio, 2016
APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.
Kasembeli AN et al.
Journal of the American Society of Nephrology : Jasn, 2015
In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress.
Anderson BR et al.
Plos Genetics, 2015
Select a paper to view details